Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients

[1]  U. Sechtem,et al.  Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. , 2014, European heart journal cardiovascular Imaging.

[2]  K. Klingel,et al.  Cause of cardiac disease in a female carrier of Duchenne muscular dystrophy: myocarditis versus genetic cardiomyopathy without skeletal myopathy? , 2014, Circulation.

[3]  Sabino Iliceto,et al.  Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. , 2014, Heart rhythm.

[4]  C. Kramer,et al.  Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis , 2014, Circulation. Cardiovascular imaging.

[5]  Tevfik F Ismail,et al.  The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy , 2013, Circulation.

[6]  I. Takeuchi,et al.  Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy , 2013, Heart and Vessels.

[7]  N. Dahdah,et al.  All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. , 2013, Journal of the American College of Cardiology.

[8]  D. Leosco,et al.  Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized Trials , 2013, PloS one.

[9]  S. Neubauer,et al.  Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis , 2013, Heart Failure Reviews.

[10]  E. Bertini,et al.  Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype , 2012, BMC Medical Genetics.

[11]  Kevin M Flanigan,et al.  The Muscular Dystrophies , 1999, Seminars in Neurology.

[12]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[13]  U. Sechtem,et al.  Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy , 2012, Heart.

[14]  L. Tavazzi,et al.  Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. , 2011, Journal of the American College of Cardiology.

[15]  S. Raman,et al.  Advances in Cardiovascular Imaging Cardiac Involvement in Patients With Muscular Dystrophies Magnetic Resonance Imaging Phenotype and Genotypic Considerations , 2011 .

[16]  G. Dangas,et al.  Cardiovascular magnetic resonance imaging evaluation of two families with Becker muscular dystrophy , 2010, Neuromuscular Disorders.

[17]  Y. Pinto,et al.  Hereditary muscular dystrophies and the heart , 2010, Neuromuscular Disorders.

[18]  A. Pestronk,et al.  Analysis of Dystrophin Deletion Mutations Predicts Age of Cardiomyopathy Onset in Becker Muscular Dystrophy , 2009, Circulation. Cardiovascular genetics.

[19]  J. Wansapura,et al.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. , 2009, Journal of the American College of Cardiology.

[20]  G. Thiene,et al.  Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[21]  J. Finsterer,et al.  Cardiac involvement in Becker muscular dystrophy. , 2008, The Canadian journal of cardiology.

[22]  A. Toutain,et al.  Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. , 2007, American heart journal.

[23]  C. Rochitte,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. , 2007, Journal of the American College of Cardiology.

[24]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[25]  G. van Ommen,et al.  Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule , 2006, Muscle & nerve.

[26]  W. Stevenson,et al.  Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.

[27]  R. Ohye,et al.  Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Jefferies J, Eidem B, Belmont J, Craigen W, Ware S, Fernbach S, Neish S, Smith E, Towbin J (2005) Circulation 112: 2799-2804: Commentary , 2005 .

[28]  Univ.-Doz. DDr. J. Finsterer,et al.  The heart in muscular dystrophies , 2005, Zeitschrift für Kardiologie.

[29]  J. Belmont,et al.  Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy , 2005, Circulation.

[30]  A. Carsana,et al.  Analysis of Dystrophin Gene Deletions Indicates that the Hinge III Region of the Protein Correlates with Disease Severity , 2005 .

[31]  F. Salvatore,et al.  Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity. , 2005, Annals of human genetics.

[32]  H. Bécane,et al.  Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. , 2005, Journal of the American College of Cardiology.

[33]  L. Politano,et al.  Mutation of dystrophin gene and cardiomyopathy , 1994, Neuromuscular Disorders.

[34]  S. Hunter.  The heart in muscular dystrophy. , 1980, British medical bulletin.